Consensus $14.18. Backs FY25 revenue view $21.8B-$21.9B, consensus $21.82B. The company said, “The company raised its full-year adjusted EPS guidance to $14.30 to $14.45, reflecting an $0.18 increase to 9.4% growth at the midpoint. This reflects strong Q3 operating performance and incremental investments in selling and marketing in Q4. The company reaffirmed its organic revenue growth guidance of 3.0% to 3.5%. For the full fiscal year, the company now estimates the impact of translational foreign currency to be an increase of approximately $10 million to revenue year over year and about neutral to adjusted EPS.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX:
- Becton Dickinson reports Q3 adjusted EPS $3.68, consensus $3.40
- Notable companies reporting before tomorrow’s open
- BDX Earnings this Week: How Will it Perform?
- Becton Dickinson to invest $35M to expand prefilled flush syringe manufacturing
- Becton Dickinson receives FDA clearance for BD Veritor System for SARS-CoV-2